Protalix BioTherapeutics
PLX
$1.21
Share price
0.83%
Change (1 day)
-49.79%
Change (1 year)
Categories
Number of shares outstanding for Protalix BioTherapeutics (PLX)
Number of shares outstanding as of April 2024 : 72,281,681
According to Protalix BioTherapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 72,281,681. At the end of 2023 the company had 72,281,681 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Protalix BioTherapeutics from 2020 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 72.28 M | 46.03% |
| 2022 | 49.49 M | 8.65% |
| 2021 | 45.55 M | 38.62% |
| 2020 | 32.86 M | 121.48% |
| 2019 | 14.83 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 7,712.49% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | 97,900,000 | 35.44% | 🇺🇸 USA |
 Amicus Therapeutics
FOLD | 295,759,435 | 309.18% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 1,450.88% | 🇮🇱 Israel |